Found: 27
Select item for more details and to access through your institution.
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides.
- Published in:
- Nature Communications, 2024, v. 15, p. 1, doi. 10.1038/s41467-024-46408-3
- By:
- Publication type:
- Article
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 31, doi. 10.3390/cancers15010031
- By:
- Publication type:
- Article
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 5, p. 656, doi. 10.1038/s41587-021-01072-6
- By:
- Publication type:
- Article
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.
- Published in:
- BioImpacts, 2022, v. 12, n. 2, p. 65, doi. 10.34172/bi.2021.23511
- By:
- Publication type:
- Article
Polymer Nanoparticle-Mediated Delivery of Oxidized Tumor Lysate-Based Cancer Vaccines.
- Published in:
- Macromolecular Bioscience, 2022, v. 22, n. 2, p. 1, doi. 10.1002/mabi.202100356
- By:
- Publication type:
- Article
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer.
- Published in:
- BioImpacts, 2022, v. 12, n. 1, p. 65, doi. 10.34172/bi.2021.23511
- By:
- Publication type:
- Article
A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5801, doi. 10.3390/cancers13225801
- By:
- Publication type:
- Article
Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5819, doi. 10.3390/cancers13225819
- By:
- Publication type:
- Article
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4553, doi. 10.3390/cancers13184553
- By:
- Publication type:
- Article
Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.695150
- By:
- Publication type:
- Article
Unsupervised Analysis of Flow Cytometry Data in a Clinical Setting Captures Cell Diversity and Allows Population Discovery.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.633910
- By:
- Publication type:
- Article
Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 271, doi. 10.3390/vaccines8020271
- By:
- Publication type:
- Article
Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 25, doi. 10.3390/vaccines8010025
- By:
- Publication type:
- Article
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.15252/emmm.201910681
- By:
- Publication type:
- Article
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01832
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1859, doi. 10.1007/s00259-019-04348-x
- By:
- Publication type:
- Article
Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00766
- By:
- Publication type:
- Article
Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 40, doi. 10.3390/cancers11010040
- By:
- Publication type:
- Article
Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
- Published in:
- Vaccines, 2018, v. 6, n. 4, p. 79, doi. 10.3390/vaccines6040079
- By:
- Publication type:
- Article
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.
- Published in:
- PLoS Computational Biology, 2017, v. 13, n. 8, p. 1, doi. 10.1371/journal.pcbi.1005725
- By:
- Publication type:
- Article
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-149
- By:
- Publication type:
- Article
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- clinical trial
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 157, doi. 10.1186/1479-5876-10-157
- By:
- Publication type:
- Article
Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028732
- By:
- Publication type:
- Article
Differentially expressed nucleolar transforming growth factor-{beta}1 target (DENTT) exhibits an inhibitory role on tumorigenesis.
- Published in:
- Carcinogenesis, 2008, v. 29, n. 6, p. 1282, doi. 10.1093/carcin/bgn087
- By:
- Publication type:
- Article